Acarbose Tablet
Product Images NDC 64380-759

6 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Acarbose (NDC 64380-759). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

96e161be A386 4fa4 875d De32db641792 01

96e161be A386 4fa4 875d De32db641792 01
Chemical structure of acarbose, showing its molecular arrangement with multiple hydroxyl groups and sugar moieties characteristic of this oral prescription drug.*
FDA Label Image

96e161be A386 4fa4 875d De32db641792 02

96e161be A386 4fa4 875d De32db641792 02
Bar chart showing mean change in plasma glucose (mg/dL) by dose of Acarbose tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg) administered three times daily (t.i.d.). Each bar represents the mean plasma glucose change with corresponding sample sizes (N) indicated above each bar.*
FDA Label Image

96e161be A386 4fa4 875d De32db641792 03

96e161be A386 4fa4 875d De32db641792 03
A figure containing four line graphs labeled A to D comparing treatments: Diet, Sulfonylurea, Metformin, and Insulin over 12 months. Each graph shows changes over time (in months) on the x-axis against a numerical scale on the y-axis ranging approximately from -1.5 to 1.5, depicting trends or outcomes for each treatment category.*
FDA Label Image

96e161be A386 4fa4 875d De32db641792 04

96e161be A386 4fa4 875d De32db641792 04
Acarbose 25 mg tablets label showing a 100-count package for oral use. The label includes dosing and storage instructions, manufacturer and distributor information, and barcode. It is produced by Strides Pharma Science Limited, Bengaluru, India, and distributed by Strides Pharma Inc., East Brunswick, NJ.*
FDA Label Image

96e161be A386 4fa4 875d De32db641792 05

96e161be A386 4fa4 875d De32db641792 05
Acarbose Tablets oral medication label showing 50 mg strength. The label states each tablet contains acarbose 50 mg and the package includes 100 tablets. It is manufactured and distributed by Strides Pharma Science Limited, India, and Strides Pharma Inc., NJ, USA. Storage instructions specify keeping the container tightly closed at 20° to 25°C. The label includes an NDC number 64380-759-06 and space for batch details.*
FDA Label Image

96e161be A386 4fa4 875d De32db641792 06

96e161be A386 4fa4 875d De32db641792 06
Label for Acarbose Tablets 100 mg oral tablets by Strides Pharma Science Limited. The label includes dosage form, strength, and quantity (100 tablets). Storage instructions and manufacturer/distributor details are shown. Features NDC 64380-760-06 and space for batch details with barcodes on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.